Medpace Holdings, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Medpace Holdings, Inc. (MEDP) holds an ST Score of 44.8 out of 100 (C+), with its strongest factor being Profitability (A) and its weakest Sentiment (F). Analysts rate MEDP Hold across 19 ratings with a $606.38 average price target (-0.0% vs the current $612.33).
- Strongest
- ProfitabilityA
- Weakest
- SentimentF
All factor grades
- ProfitabilityA
- GrowthB+
- Financial StrengthC+
- MomentumC
- ForecastC-
- ValuationD-
- SentimentF
- Piotroski7/9
Contact
MEDP stock: frequently asked questions
What is MEDP's ST Score?
Medpace Holdings, Inc. (MEDP) has an ST Score of 44.8 out of 100, an overall grade of C+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is MEDP a buy, sell, or hold?
Wall Street's consensus rating on MEDP is Hold based on 19 analyst ratings. Our own ST Score grades it C+ (44.8/100). This is data, not investment advice — always do your own research.
What is MEDP's valuation grade?
Medpace Holdings, Inc. (MEDP) earns a valuation grade of D-, measured against Medical - Diagnostics & Research peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is MEDP's growth grade?
Medpace Holdings, Inc. (MEDP) earns a growth grade of B+, measured against Medical - Diagnostics & Research peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is MEDP's profitability grade?
Medpace Holdings, Inc. (MEDP) earns a profitability grade of A, measured against Medical - Diagnostics & Research peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is MEDP's financial strength grade?
Medpace Holdings, Inc. (MEDP) earns a financial strength grade of C+, measured against Medical - Diagnostics & Research peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for MEDP?
The average analyst price target for Medpace Holdings, Inc. (MEDP) is $606.38 from 19 analysts, which is -0.0% versus the recent price of $612.33.
What is MEDP's Piotroski score?
Medpace Holdings, Inc. (MEDP) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.